Pharmena – Science-Driven Life Science Company
Pharmena SA is a publicly listed life science company focused on translating scientific discoveries into innovative products and technologies. The Company combines research, development and commercialization of solutions addressing important health and longevity challenges.
Our activities are built on years of scientific research around 1-methylnicotinamide (1-MNA) – a naturally occurring molecule with unique biological properties and broad potential applications.
Pharmena develops its activities across complementary areas including longevity solutions, topical technologies and bioscience focused on the biological potential of the 1-MNA molecule.
Pharmena – Science-Driven Life Science Company
Pharmena SA is a publicly listed life science company focused on translating scientific discoveries into innovative products and technologies. The Company combines research, development and commercialization of solutions addressing important health and longevity challenges.
Our activities are built on years of scientific research around 1-methylnicotinamide (1-MNA) – a naturally occurring molecule with unique biological properties and broad potential applications.
Pharmena develops its activities across complementary areas including longevity solutions, topical technologies and bioscience focused on the biological potential of the 1-MNA molecule.
1-MNA – The Scientific Foundation
1-methylnicotinamide (1-MNA) is a naturally occurring molecule produced in the human body during the metabolism of niacin (vitamin B3). It is associated with important biological processes related to vascular function, metabolic balance and cellular vitality.
Over the past two decades, researchers from leading scientific institutions worldwide have conducted extensive studies exploring the biological properties of 1-MNA and its potential applications.
Pharmena has built its innovation strategy around this molecule, combining scientific expertise, proprietary know-how and intellectual property protection to develop new product solutions and technologies.
1-MNA – The Scientific Foundation
1-methylnicotinamide (1-MNA) is a naturally occurring molecule produced in the human body during the metabolism of niacin (vitamin B3). It is associated with important biological processes related to vascular function, metabolic balance and cellular vitality.
Over the past two decades, researchers from leading scientific institutions worldwide have conducted extensive studies exploring the biological properties of 1-MNA and its potential applications.
Pharmena has built its innovation strategy around this molecule, combining scientific expertise, proprietary know-how and intellectual property protection to develop new product solutions and technologies.
Advancing Science.
Creating Value.
contact
PHARMENA S.A.
ul. Gdanska 47/49
90-729 Łodz, Poland
phone: +48 42 280 77 07
office@pharmena.eu
links
Advancing Science.
Creating Value.
contact
PHARMENA S.A.
ul. Gdanska 47/49
90-729 Łodz, Poland
phone: +48 42 280 77 07
office@pharmena.eu